electronic supporting information for eu(iii)(hfa)3 in ... · morinomiya, joto-ku, osaka 536-8553,...
TRANSCRIPT
Electronic Supporting Information for
Can chiral P(III) coordinate Eu(III)? Unexpected solvent dependent circularly polarised luminescence of BINAP and Eu(III)(hfa)3 in chloroform and acetone
Yuki Kono,a Kazuki Nakabayashi,a Sayaka Kitamura,a Motohiro Shizuma,b Michiya Fujikic*
and Yoshitane Imaia*
a Department of Applied Chemistry, Faculty of Science and Engineering, Kindai University, 3-4-1 Kowakae, Higashi-Osaka, Osaka 577-8502, Japan.; E-mail: (Y.I.) [email protected]. b Department of Biochemistry, Osaka Municipal Technical Research Institute, 1-6-50 Morinomiya, Joto-ku, Osaka 536-8553, Japan.c Graduate School of Materials Science, Nara Institute of Science and Technology, Takayama, Ikoma, Nara 630-0192, Japan. (M.F.) [email protected].
S1
Electronic Supplementary Material (ESI) for RSC Advances.This journal is © The Royal Society of Chemistry 2016
Table of Contents
Fig. S1 Normalized CPL and PL spectra of (R)-BINAP:Eu(hfa)3 = 1:1 in EtOH-free chloroform S3
Fig. S2 Normalized CPL and PL spectra of (R)-BINAP:Eu(hfa)3 in EtOH-free chloroform S4
Fig. S3 Normalized CD and UV-vis spectra of (R)- and (S)-BINAP:Eu(hfa)3 in
EtOH-free chloroform S5
Fig. S4 Negative-mode LCMS-IT-TOF spectrum of (R)-BINAP-Eu(III) S6
Fig. S5 Positive-mode LCMS-IT-TOF spectrum of (R)-BINAP-Eu(III) S7
Fig. S6 Negative-mode electrospray MS spectrum of (R)-BINAP-Eu(III) by adding NaOTf S8
Fig. S7 Positive-mode electrospray MS spectrum of (R)-BINAP-Eu(III) with NaOTf S9
Fig. S8 1H-NMR spectrum of (R)-BINAP with Eu(hfa)3 (1:1) in CDCl3 S10
Fig. S9 1H-NMR spectrum of (R)-BINAP with Eu(hfa)3 (1:1) in acetone-d6 S11
Fig. S10 1H-NMR spectrum of (R)-BINAPO with Eu(hfa)3 (1:1) in CDCl3 S12
Fig. S11 1H-NMR spectrum of (R)-BINAPO with Eu(hfa)3 (1:1) in acetone-d6 S13
Fig. S12 31P-NMR spectrum of (R)-BINAP with Eu(hfa)3 (1:1) in CDCl3 S14
Fig. S13 31P-NMR spectrum of (R)-BINAP in CDCl3
S14
Fig. S14 31P-NMR spectrum of (R)-BINAPO with Eu(hfa)3 (1:1) in CDCl3 S15
Fig. S15 31P-NMR spectrum of (R)-BINAPO in CDCl3 S15
Fig. S16 19F-NMR spectrum of hfa in CDCl3 S16
Fig. S17 19F-NMR spectrum of Eu(hfa)3 in CDCl3 S16
Fig. S18 19F-NMR spectra of (R)-BINAP and Eu(hfa)3 (1:1) in CDCl3 S17
Fig. S19 19F-NMR spectra of (R)-BINAPO and Eu(hfa)3 (1:1) in CDCl3 S17
S2
(a) (b)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
-4
-3
-2
-1
0
1
2
500 550 600 650 700 750 I= 1
/2 •
(I L+
I R)
103
• ΔI =
I L –
I R
Wavelength / nm
(R)
Fig. S1. Normalized CPL and PL spectra of (R)-BINAP:Eu(hfa)3 = 1:1 in EtOH-free chloroform. Path length 1.0 mm. (a) [Eu(hfa)3] = 1×10–5 M. ex = 300 nm, gem = +1.6 × 10–2 (593 nm), –0.95 × 10–3 (618nm). (b) [Eu(hfa)3] = 1×10–4 M. ex = 300 nm, gem = +1.4 × 10–2 (592 nm), –0.92 × 10–3 (613 nm).
S3
(a) (b)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
-2
-1
0
1
500 550 600 650 700 750 I= 1
/2 •
(I L+
I R)
103
• ΔI =
I L –
I R
Wavelength / nm
(R)
(S)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
-4
-3
-2
-1
0
1
2
500 550 600 650 700 750 I= 1
/2 •
(I L+
I R)
103
• ΔI =
I L –
I R
Wavelength / nm
(R)
(S)
(c) (d)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
-4
-3
-2
-1
0
1
2
500 550 600 650 700 750 I= 1
/2 •
(I L+
I R)
103
• ΔI =
I L –
I R
Wavelength / nm
(R)
Fig. S2. Normalized CPL and PL spectra of (R)-BINAP:Eu(hfa)3 in EtOH-free chloroform, [Eu(hfa)3] = 5 × 10–4 M (path length 1.0 mm). (a) (R)- (and (S))-BINAP:Eu(hfa)3 = 1:2, ex = 325 nm, gem for (R) = +0.89×10–2 (592 nm), –0.75×10–3 (617 nm), gem for (S) = –0.89×10–2 (592 nm), +0.75 × 10–3 (617 nm). (b) (R)- (and (S))-BINAP:Eu(hfa)3 = 2:1, ex = 325 nm, gem for (R) = +1.3 × 10–2 (592 nm), –1.15 × 10–3 (615 nm), gem for (S) = –1.3 × 10–2 (592 nm), +0.85 × 10–3 (615 nm). (c) (R)-BINAP:Eu(hfa)3 = 5:1, ex = 335 nm, gem = +1.0 × 10–2 (592 nm), –1.6 × 10–3 (618 nm). (d) (R)-BINAP:Eu(hfa)3 = 10:1, ex = 335 nm, gem = +1.1×10–2 (592 nm), –1.1×10–3 (613 nm).
S4
(a) (b)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
-20
-15
-10
-5
0
5
10
245 300 355 410 465 ε=
1/2
• (ε L
+ ε
R) /
104
M-1
cm-1
Δε=
ε L –
ε R/ M
-1 c
m-1
Wavelength / nm
(R)
(S)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
-20
-15
-10
-5
0
5
10
200 250 300 350 400 450 500 ε=
1/2
• (ε L
+ ε
R) /
104
M-1
cm-1
Δε=
ε L –
ε R/ M
-1 c
m-1
Wavelength / nm
(R)
(S)
(c) (d)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
-20
-15
-10
-5
0
5
10
245 300 355 410 465 ε=
1/2
• (ε L
+ ε
R) /
104
M-1
cm-1
Δε=
ε L –
ε R/ M
-1 c
m-1
Wavelength / nm
(R)
(S)
(e)
Fig. S3. Normalized CD and UV-vis spectra of (R)- and (S)-BINAP:Eu(hfa)3 in EtOH-free chloroform. [Eu(hfa)3] = 5 × 10–4 M (path length 1.0 mm). (a) (R)- and (S)-BINAP:Eu(hfa)3 = 1:2, |gabs| = 2.6 × 10–4 at 336 nm. (b) (R)- and (S)-BINAP: Eu(hfa)3 = 1:1, |gabs| = 5.8 × 10–4 at 336 nm. (c) (R)- and (S)-BINAP:Eu(hfa)3 = 2:1, |gabs| = 7.4 × 10–4 at 336 nm. (d) (R)-BINAP:Eu(hfa)3 = 5:1, gabs = +9.0 × 10–4 at 335 nm. (e) (R)-BINAP:Eu(hfa)3 = 10:1, gabs = +9.4 × 10–4 at 335 nm.
S5
Negative mode (full range)
100 200 300 400 500 600 700 800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800 1900 m/z0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
Inten.(x100,000)
206.9783
980.8188(1)
436.9408
660.8902(1)
m/z= 206.99: hfa, m/z= 660.89: BINAP, m/z= 980.82: BINAP+Eu+hfa
Negative mode (zoom-in)
977.0 978.0 979.0 980.0 981.0 982.0 983.0 984.0 985.0 986.0 m/z0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0Inten.(x100,000)
980.8188(1)
978.8171(1)
m/z = 978.82: 151Eu+BINAP+HFA, m/z= 980.82: 153Eu+BINAP+HFA
Fig. S4. Negative-mode LCMS-IT-TOF spectra of (R)-BINAP-Eu(III). Top; full spectrum. Bottom; its zoom-in spectrum.
S6
Positive mode (full)
100 200 300 400 500 600 700 800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800 1900 m/z0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
Inten.(x100,000)
437.1292(1)
623.1809(1)
318.9955
677.1485(1)
Positive mode (zoom-in)
934.5 935.0 935.5 936.0 936.5 937.0 937.5 938.0 938.5 939.0 939.5 940.0 940.5 941.0 941.5 m/z0.0
2.5
5.0
7.5
Inten.(x1,000)
Fig. S5. Positive-mode LCMS-IT-TOF spectra of (R)-BINAP-Eu(III). Top; full spectrum. Bottom; its zoom-in spectrum.
S7
Negative mode (full)
250 500 750 1000 1250 1500 1750 m/z0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
Inten.(x100,000)
112.9860
582.8913(1)
226.9742
488.8879(1)
394.8876
Negative mode (zoom-in)
672.5 675.0 677.5 680.0 682.5 685.0 687.5 m/z0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0Inten.(x100,000)
676.8913(1)
678.8924(1)
Fig. S6. Negative-mode electrospray MS spectrum of (R)-BINAP-Eu(III) by adding Na triflate. Two Eu(III) isotopic species with a natural abundance around m/z= 676.89 and 678.89 were observed. However, no distinct parent peaks of Eu(III)(hfa)3-BINAP (m/z= 1396.08 and 1398.08) with Na+ (m/z = 22.99) triflate (m/z = 148.95) without H2O (m/z = 18.01) and two or three H2O molecules as adducts were detected.
S8
Positive mode (full)
250 500 750 1000 1250 1500 1750 m/z0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0Inten.(x1,000,000)
655.1904(1)
Fig. S7. Positive-mode electrospray MS spectrum of (R)-BINAP-Eu(III) with NaOTf. Any Eu(III) isotopic species with natural abundance around m/z= 670 and 980 were not observed. No distinct parent peaks of Eu(III)(hfa)3-BINAP (m/z= 1396.08 and 1398.08) with Na+ (m/z = 22.99) triflate (m/z = 148.95) without H2O (m/z = 18.01) and two/three H2O molecules as adducts were detected.
S9
abun
danc
e0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
1.1
1.2
1.3
1.4
1.5
X : parts per Million : Proton
12.0 11.0 10.0 9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0
7.
891
7.
878
7.
833
7.
822
7.
446
7.
436
7.
344
7.
260
7.
150
7.
106
7.
059
6.
908
6.
831
1.
704
0.
000
35.0
0
abun
danc
e0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
1.1
1.2
1.3
1.4
1.5
X : parts per Million : Proton
8.6 8.5 8.4 8.3 8.2 8.1 8.0 7.9 7.8 7.7 7.6 7.5 7.4 7.3 7.2 7.1 7.0 6.9 6.8 6.7 6.6 6.5 6.4 6.3 6.2 6.1 6.0 5.9
7.
891
7.
878
7.
833
7.
822
7.
446
7.
436
7.
344
7.
260
7.
150
7.
106
7.
059
6.
908
6.
831
35.0
0
Fig. S8. 1H-NMR spectra of (R)-BINAP with Eu(hfa)3 (1:1) in CDCl3.1H-NMR signals at 7.260 ppm and 1.574 ppm are due to residual CHCl3 and H2O.
S10
abun
danc
e0
0.1
0.2
0.3
0.4
0.5
0.6
X : parts per Million : Proton
12.0 11.0 10.0 9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0
7.
984
7.
970
7.
913
7.
899
7.
226
7.
221
7.
212
7.
168
6.
769
6.
754
3.
824
3.
591
3.
354
3.
025
2.
995
2.
544
2.
040
2.
037
2.
033
2.
030
1.
264
1.
158
1.
123
1.
017
0.
891
0.
105
-0.
027
35.0
0
abun
danc
e0
0.1
0.2
0.3
0.4
0.5
0.6
X : parts per Million : Proton
8.5 8.4 8.3 8.2 8.1 8.0 7.9 7.8 7.7 7.6 7.5 7.4 7.3 7.2 7.1 7.0 6.9 6.8 6.7 6.6 6.5 6.4 6.3 6.2
7.
984
7.
970
7.
913
7.
899
7.
415
7.
411
7.
401
7.
396
7.
388
7.
377
7.
363
7.
226
7.
221
7.
218
7.
212
7.
180
7.
168
7.
096
7.
094
7.
038
6.
954
6.
945
6.
943
6.
930
6.
769
6.
754
35.0
0
Fig. S9. 1H-NMR spectra of (R)-BINAP with Eu(hfa)3 (1:1) in acetone-d6.
S11
abun
danc
e0
0.1
0.2
0.3
0.4
0.5
0.6
X : parts per Million : Proton
12.0 11.0 10.0 9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0
8.
585
8.
231
8.
116
7.
983
7.
834
7.
589
7.
391
7.
263
7.
148
7.
075
6.
873
6.
568
6.
370
6.
158
6.
059
2.
171
2.
104
1.
851
0.
000
35.0
0
abun
danc
e0
0.1
0.2
0.3
0.4
0.5
0.6
X : parts per Million : Proton
9.2 9.1 9.0 8.9 8.8 8.7 8.6 8.5 8.4 8.3 8.2 8.1 8.0 7.9 7.8 7.7 7.6 7.5 7.4 7.3 7.2 7.1 7.0 6.9 6.8 6.7 6.6 6.5 6.4 6.3 6.2 6.1 6.0 5.9 5.8 5.7 5.6 5.5 5.4 5.3
8.
585
8.
231
8.
116
7.
983
7.
834
7.
589
7.
391
7.
263
7.
148
7.
075
6.
873
6.
568
6.
370
6.
158
6.
059
35.0
0
Fig. S10. 1H-NMR spectra of (R)-BINAPO with Eu(hfa)3 (1:1) in CDCl3.
S12
abun
danc
e0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.1
0.11
X : parts per Million : Proton
12.0 11.0 10.0 9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0
8.
787
8.
776
8.
292
8.
278
7.
978
7.
660
7.
402
7.
390
7.
207
7.
007
6.
654
6.
640
6.
237
3.
822
3.
272
2.
924
2.
893
2.
545
2.
043
2.
040
2.
037
2.
033
1.
269
1.
163
0.
897
-0.
023
35.0
0
abun
danc
e0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.1
0.11
X : parts per Million : Proton
9.3 9.2 9.1 9.0 8.9 8.8 8.7 8.6 8.5 8.4 8.3 8.2 8.1 8.0 7.9 7.8 7.7 7.6 7.5 7.4 7.3 7.2 7.1 7.0 6.9 6.8 6.7 6.6 6.5 6.4 6.3 6.2 6.1 6.0 5.9 5.8 5.7 5.6 5.5 5.4 5.3
8.
787
8.
776
8.
292
8.
278
7.
978
7.
964
7.
775
7.
672
7.
660
7.
648
7.
518
7.
449
7.
402
7.
390
7.
207
7.
149
7.
136
7.
124
7.
007
6.
995
6.
816
6.
761
6.
654
6.
640
6.
608
6.
237
35.0
0
Fig. S11. 1H-NMR spectra of (R)-BINAPO with Eu(hfa)3 (1:1) in acetone-d6.
S13
abun
danc
e0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
X : parts per Million : Phosphorus31
300.0 200.0 100.0 0 -100.0 -200.0 -300.0
-15.
052
Fig. S12. 31P-NMR spectrum of (R)-BINAP with Eu(hfa)3 (1:1 in molar ratio) in CDCl3.31P resonances at -15.052 ppm using a reference 31P peak (at 140 ppm) of P(OMe)3 in MeOD.
abun
danc
e0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
9.0
10.0
11.0
12.0
13.0
14.0
X : parts per Million : Phosphorus31
300.0 200.0 100.0 0 -100.0 -200.0 -300.0
-14.
862
Fig. S13. 31P-NMR spectrum of (R)-BINAP in CDCl3. 31P resonances at –14.862 ppm. 500-1000 acquisitions. Sample (5–10 mg) was dissolved in 0.6 mL of CDCl3,
corresponding to (0.6–1.2) x 10–2 M.
S14
abun
danc
e 00.
10.
20.
30.
40.
5
X : parts per Million : Phosphorus31
110.0 100.0 90.0 80.0 70.0 60.0 50.0 40.0 30.0 20.0 10.0 0 -10.0 -20.0 -30.0 -40.0 -50.0 -60.0 -70.0 -80.0 -90.0 -100.0 -110.0
28.
885
-65.
702
-69.
167
Fig. S14. 31P-NMR spectrum of (R)-BINAPO with Eu(hfa)3 (1:1 in molar ratio) in CDCl3.Major 31P signal at -69.167 infers the coordination of P(V)=O of BINAPO, whilst minor 31P signal at +28.885 ppm is non-coordinated P(V)=O of BINAPO. The origin of minor 31P-
NMR signal at -65.702 ppm is unclear. 500–1000 acquisitions. Sample (5-10 mg) was dissolved in 0.6 mL of CDCl3, corresponding to (0.6–1.2) x 10–2 M.
abun
danc
e0
1.0
2.0
3.0
X : parts per Million : Phosphorus31
300.0 200.0 100.0 0 -100.0 -200.0 -300.0
28.
912
Fig. S15. 31P-NMR spectrum of (R)-BINAPO in CDCl3. 31P resonances at +28.912 ppm.
S15
abun
danc
e0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.
011
0.0
120.
0
X : parts per Million : Fluorine19
50.0 40.0 30.0 20.0 10.0 0 -10.0 -20.0 -30.0 -40.0 -50.0 -60.0 -70.0 -80.0 -90.0 -100.0 -110.0 -120.0 -130.0 -140.0 -150.0 -160.0 -170.0 -180.0 -190.0
-76.
500
Fig. S16. 19F-NMR spectrum of hfa in CDCl3. 19F resonances at −76.500 ppm.
abun
danc
e-0
.02-0
.01
00.
010.
020.
030.
040.
050.
060.
070.
080.
090.
10.
110.
120.
130.
140.
150.
160.
17
X : parts per Million : Fluorine19
50.0 40.0 30.0 20.0 10.0 0 -10.0 -20.0 -30.0 -40.0 -50.0 -60.0 -70.0 -80.0 -90.0 -100.0 -110.0 -120.0 -130.0 -140.0 -150.0 -160.0 -170.0 -180.0 -190.0
-79.
059
Fig. S17. 19F-NMR spectrum of Eu(hfa)3 in CDCl3. 19F resonances at −79.059 ppm.
S16
abun
danc
e0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
X : parts per Million : Fluorine19
50.0 40.0 30.0 20.0 10.0 0 -10.0 -20.0 -30.0 -40.0 -50.0 -60.0 -70.0 -80.0 -90.0 -100.0 -110.0 -120.0 -130.0 -140.0 -150.0 -160.0 -170.0 -180.0 -190.0
-79.
069
-80.
057
Fig. S18. 19F-NMR spectrum of (R)-BINAP and Eu(hfa)3 ( = 1:1 in molar ratio) in CDCl3.19F resonances at −79.099 ppm (major) and −80.057 ppm (minor).
abun
danc
e0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
9.0
10.0
11.0
X : parts per Million : Fluorine19
50.0 40.0 30.0 20.0 10.0 0 -10.0 -20.0 -30.0 -40.0 -50.0 -60.0 -70.0 -80.0 -90.0 -100.0 -110.0 -120.0 -130.0 -140.0 -150.0 -160.0 -170.0 -180.0 -190.0
-78.
009
-78.
549
Fig. S19. 19F-NMR spectrum of (R)-BINAPO and Eu(hfa)3 ( = 1:1 in molar ratio) in CDCl3. 19F resonances at −78.099 ppm (minor) and −78.549 ppm (major).
S17